Reverse Convertible Bonds Finder
Your selection:
17 Results
| BD03C3 |  | BioNTech SE (ADRs)/Aktienanleihe/21,75%/Call/VONT | - | - | 21.750% | 23.187% | BioNTech SE (ADRs) | 90.000 | 12/28/2026 | 11.111110 | Vontobel | |
| HV4Z4N | | BioNTech SE (ADRs)/Aktienanleihe/8%/Call/UniCredit | - | - | 8.000% | 15.176% | BioNTech SE (ADRs) | 82.512 | 11/11/2026 | 12.119449 | Unicredit | |
| VH24CA | | BioNTech SE (ADRs)/Aktienanleihe/11%/Call/VONT | - | - | 11.000% | 42.900% | BioNTech SE (ADRs) | 98.720 | 09/25/2026 | 10.129660 | Vontobel | |
| VH7YEW | | BioNTech SE (ADRs)/Aktienanleihe/14,75%/Call/VONT | - | - | 14.750% | - | BioNTech SE (ADRs) | 117.000 | 01/05/2027 | 8.547010 | Vontobel | |
| VH99AH | | BioNTech SE (ADRs)/Aktienanleihe/11,25%/Call/VONT | - | - | 11.250% | 23.207% | BioNTech SE (ADRs) | 92.170 | 12/28/2026 | 10.849517 | Vontobel | |
| VH9MUK | | Multi/Aktienanleihe/22,25%/Call/VONT | - | - | 22.250% | - | BioNTech SE (ADRs) | 25.770 | 12/28/2026 | 10.279605 | Vontobel | |
| VJ1AX8 | | BioNTech SE (ADRs)/Aktienanleihe/21,25%/Call/VONT | - | - | 21.250% | 5.640% | BioNTech SE (ADRs) | 120.000 | 03/29/2027 | 8.333330 | Vontobel | |
| VJ69HH | | BioNTech SE (ADRs)/Aktienanleihe/12%/Call/VONT | - | - | 12.000% | 18.647% | BioNTech SE (ADRs) | 90.540 | 03/30/2027 | 11.044840 | Vontobel | |
| VY1L26 | | BioNTech SE (ADRs)/Aktienanleihe/13,25%/Call/VONT | - | - | 13.250% | 23.451% | BioNTech SE (ADRs) | 102.060 | 05/28/2027 | 9.798160 | Vontobel | |
| VY25DP | | BioNTech SE (ADRs)/Aktienanleihe/15,75%/Call/VONT | - | - | 15.750% | 23.528% | BioNTech SE (ADRs) | 90.000 | 12/28/2026 | 11.111110 | Vontobel | |
| VY25DS | | BioNTech SE (ADRs)/Aktienanleihe/21,25%/Call/VONT | - | - | 21.250% | 14.493% | BioNTech SE (ADRs) | 100.000 | 12/28/2026 | 10.000000 | Vontobel | |
| VY2ESE | | BioNTech SE (ADRs)/Aktienanleihe/14,75%/Call/VONT | - | - | 14.750% | 16.246% | BioNTech SE (ADRs) | 100.000 | 12/28/2026 | 10.000000 | Vontobel | |
| VY2ESF | | BioNTech SE (ADRs)/Aktienanleihe/20%/Call/VONT | - | - | 20.000% | 8.207% | BioNTech SE (ADRs) | 110.000 | 12/28/2026 | 9.090910 | Vontobel | |
| VY2ESG | | BioNTech SE (ADRs)/Aktienanleihe/9,75%/Call/VONT | - | - | 9.750% | 24.102% | BioNTech SE (ADRs) | 90.000 | 12/28/2026 | 11.111110 | Vontobel | |
| VY3HDM | | BioNTech SE (ADRs)/Aktienanleihe/11,5%/Call/VONT | - | - | 11.500% | 13.627% | BioNTech SE (ADRs) | 80.000 | 12/28/2026 | 12.500000 | Vontobel | |
| VY44TH | | BioNTech SE (ADRs)/Aktienanleihe/24,5%/Call/VONT | - | - | 24.500% | 22.203% | BioNTech SE (ADRs) | 90.000 | 12/28/2026 | 11.111110 | Vontobel | |
| VY4YNE | | Multi/Aktienanleihe/21%/Call/VONT | - | - | 21.000% | - | Fresenius SE & Co. KGaA | 92.250 | 05/28/2027 | 26.462027 | Vontobel |